35 molecular-modeling-or-molecular-dynamic-simulation Fellowship positions at City of Hope
-
qualifications should include: PhD or M.D. with a strong background and profound knowledge in molecular biology, cancer biology, and metabolism. Previous experience in working with animal models of human cancers
-
compounds, and immunotherapies. Candidates with a strong background in molecular biology, cancer research, or pharmacology who are passionate about translational science are encouraged to apply. As a
-
the project for RNA metabolism dysregulation and oncogenesis in blood malignancies. Candidates with strong background in RNA metabolism, cancer biology, and murine model are encouraged to apply
-
(poxvirus molecular biology) · Develop and characterize recombinant vaccine vectors incorporating neoantigens identified by proprietary bioinformatic pipelines and test these vaccine candidates for in
-
Institute of City of Hope invites applications for a talented Postdoctoral Fellow to join our dynamic research team. As a Postdoctoral Fellow, you'll have the opportunity to work on cutting-edge projects
-
through cutting-edge research. City of Hope is looking for a talented Postdoctoral Fellow to work on retrospective research projects that interrogate molecular signatures and prognosis in stage IV cancer
-
Your qualifications should include: · PhD or M.D. with a strong background and profound knowledge in the field of either molecular biology, immunology, cancer biology, experience in sequencing
-
at conferences; coach graduate students and technicians, and help maintain a collaborative, deadline-driven lab culture. Your qualifications should include: · Ph.D. (or imminent completion) in Molecular
-
beta-cells, aiming to identify therapeutic targets for beta-cell regeneration in diabetes. Work with mouse and human cells, mouse models, and stem cells in the context of diabetes, utilizing techniques
-
through cutting-edge research. We currently have a Postdoctoral Fellowship position available within a research team headed by Dr. Jeff Perry, Assistant Professor, Department of Cancer Biology and Molecular